安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688075 安旭生物

已收盘 05-09 15:00:01

{"stockData":{"symbol":"688075","market":"SH","secType":"STK","nameCN":"安旭生物","latestPrice":36.34,"timestamp":1746774001000,"preClose":36.93,"halted":0,"volume":460788,"delay":0,"changeRate":-0.016,"floatShares":127000000,"shares":127000000,"eps":1.2287,"marketStatus":"已收盘","change":-0.59,"latestTime":"05-09 15:00:01","open":36.74,"high":36.9,"low":36.21,"amount":16800900,"amplitude":0.0187,"askPrice":36.34,"askSize":4,"bidPrice":36.31,"bidSize":38,"shortable":0,"etf":0,"ttmEps":1.2287,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":36.93,"symbolType":"stock_kcb","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":40.62,"lowLimit":33.24,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":127082805,"isCdr":false,"pbRate":0.88,"roa":"--","peRate":29.575975,"roe":"0.65%","epsLYR":1.51,"committee":0.412844,"marketValue":4618000000,"turnoverRate":0.0036,"status":1,"afterMarket":{"amount":0,"volume":0,"close":36.34,"buyVolume":0,"sellVolume":0,"time":1746776038029,"indexStatus":"已收盘 05-09 15:30:00","preClose":36.93},"floatMarketCap":4618000000},"requestUrl":"/m/hq/s/688075","defaultTab":"news","newsList":[{"id":"2533835936","title":"杭州安旭生物科技股份有限公司液体样品检测装置专利获授权（生物检测专利快讯）","url":"https://stock-news.laohu8.com/highlight/detail?id=2533835936","media":"iDoNews","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533835936?lang=zh_cn&edition=full","pubTime":"2025-05-06 18:47","pubTimestamp":1746528423,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年5月6日，“液体样品检测装置”正式进入专利权的授权阶段。申请人为杭州安旭生物科技股份有限公司，该项生物检测装置专利涉及液体样品测试技术领域。“本实用新型提供了一种液体样品检测装置，利用开口结构保证液体样本与测试元件充分接触和流动；阻挡部能够对瞬时液体冲击进行有效阻挡，避免测试槽内发生“flooding”现象，解决了影响检测结果准确性的技术难题。”","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050618482894ede291&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050618482894ede291&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2532309004","title":"安旭生物（688075）2025年一季报简析：净利润减51.52%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2532309004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532309004?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:37","pubTimestamp":1746052632,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期安旭生物发布2025年一季报。截至本报告期末，公司营业总收入1.15亿元，同比下降10.9%，归母净利润3402.96万元，同比下降51.52%。本报告期安旭生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达95.73%。然而去年的净利率为35.55%，算上全部成本后，公司产品或服务的附加值极高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100004691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075"],"gpt_icon":0},{"id":"2531722507","title":"安旭生物一季度营收同比降10.9% 归母净利润同比跌51.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531722507","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531722507?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:32","pubTimestamp":1745994754,"startTime":"0","endTime":"0","summary":"4月29日，安旭生物公布2025年一季报，公司营业收入为1.15亿元，同比下降10.9%；归母净利润为3403万元，同比下降51.5%；扣非归母净利润为2276万元，同比上升15.9%；经营现金流净额为-1110万元，同比下降1200.4%；EPS为0.2678元。截至一季度末，公司总资产58.45亿元，较上年度末增长1.3%；归母净资产为52.36亿元，较上年度末增长0.6%。公司在研发方面持续加大投入，本期研发投入合计为2506万元，占营业收入的比例为22%，相较于上年同期有所增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043014333694e88f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043014333694e88f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075"],"gpt_icon":0},{"id":"2531763467","title":"迈瑞首现营收净利双降，医疗器械黄金十年终结？","url":"https://stock-news.laohu8.com/highlight/detail?id=2531763467","media":"CHC医疗传媒","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531763467?lang=zh_cn&edition=full","pubTime":"2025-04-30 08:05","pubTimestamp":1745971535,"startTime":"0","endTime":"0","summary":"4月28日，迈瑞医疗公布2024年报和2025年第一季度报告，现2018年以来首次季度营收和净利同比双降。众所周知，迈瑞以监护仪起家，生命信息与支持业务一直是其当家支柱。其中迈瑞位居第一名，占比59.51%；科曼、理邦、飞利浦、GE医疗同为品牌销售排行榜前五企业。以迈瑞2024年业绩为分割线，可能意味着医疗器械行业一个高体量、高增速时代的终结。众所周知，迈瑞医疗的目标是挺近全球医疗器械20强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430133918a46d3356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430133918a46d3356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159831","688613","688617","688026","688581","688067","688050","688317","600055","688217","688410","603976","688389","688301","688338","688161","688273","688366","688767","603658","603205","603309","605369","688607","688075","603301","600645","688013","688212","688253","688151","600529","603987","600587","688108","688677","159883","688575","688198"],"gpt_icon":0},{"id":"2531451798","title":"图解安旭生物一季报：第一季度单季净利润同比减51.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531451798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531451798?lang=zh_cn&edition=full","pubTime":"2025-04-30 02:57","pubTimestamp":1745953039,"startTime":"0","endTime":"0","summary":"证券之星消息，安旭生物2025年一季报显示，公司主营收入1.15亿元，同比下降10.9%；归母净利润3402.96万元，同比下降51.52%；扣非净利润2276.03万元，同比上升15.95%；负债率10.49%，投资收益2805.66万元，财务费用214.09万元，毛利率42.32%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000001766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075"],"gpt_icon":0},{"id":"2531642297","title":"图解安旭生物年报：第四季度单季净利润同比增224.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531642297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531642297?lang=zh_cn&edition=full","pubTime":"2025-04-30 01:37","pubTimestamp":1745948277,"startTime":"0","endTime":"0","summary":"证券之星消息，安旭生物2024年年报显示，公司主营收入5.41亿元，同比上升7.42%；归母净利润1.92亿元，同比上升35.85%；扣非净利润3789.79万元，同比下降27.6%；其中2024年第四季度，公司单季度主营收入1.37亿元，同比下降26.59%；单季度归母净利润5651.16万元，同比上升224.79%；单季度扣非净利润1851.91万元，同比上升139.59%；负债率9.87%，投资收益1.18亿元，财务费用-3837.7万元，毛利率39.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000001097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075"],"gpt_icon":0},{"id":"2531776730","title":"安旭生物拟每10股派发现金红利8元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531776730","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531776730?lang=zh_cn&edition=full","pubTime":"2025-04-29 20:43","pubTimestamp":1745930580,"startTime":"0","endTime":"0","summary":"4月29日，安旭生物（688075）发布公告，公司拟向全体股东每10股派发现金红利8元（含税），预计总派发金额为1.02亿元，占归母净利润的52.87%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-04-29/doc-ineuvxpt4966532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2531271217","title":"安旭生物04月29日主力净流入42万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2531271217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531271217?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:20","pubTimestamp":1745911200,"startTime":"0","endTime":"0","summary":"04月29日, 安旭生物股价涨2.59%，报收36.90元，成交金额1322.6万元，换手率0.28%，振幅3.39%，量比0.94。安旭生物今日主力资金净流入42万元，上一交易日主力净流出313万元。该股近5个交易日下跌0.94%，主力资金累计净流出372万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1739万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429163221a6ccef8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429163221a6ccef8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2529371506","title":"安旭生物收盘上涨1.20%，滚动市盈率23.54倍，总市值47.34亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529371506","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529371506?lang=zh_cn&edition=full","pubTime":"2025-04-22 18:53","pubTimestamp":1745319232,"startTime":"0","endTime":"0","summary":"4月22日，安旭生物今日收盘37.25元，上涨1.20%，滚动市盈率PE达到23.54倍，创13天以来新低，总市值47.34亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均48.08倍，行业中值30.21倍，安旭生物排名第56位。截至2024年三季报，共有1家机构持仓安旭生物，其中基金1家，合计持股数16.47万股，持股市值0.07亿元。最新一期业绩显示，2024年三季报，公司实现营业收入4.03亿元，同比27.56%；净利润1.36亿元，同比-27.33%，销售毛利率42.11%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/22185349761015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2518202438","title":"安旭生物获得外观设计专利授权：“凝血检验盘片”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518202438?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:14","pubTimestamp":1741634076,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示安旭生物新获得一项外观设计专利授权，专利名为“凝血检验盘片”，专利申请号为CN202430353581.1，授权日为2025年3月11日。今年以来安旭生物新获得专利授权4个，较去年同期减少了42.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100003347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2517676709","title":"安旭生物03月05日获主力加仓45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517676709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517676709?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:21","pubTimestamp":1741159268,"startTime":"0","endTime":"0","summary":"03月05日, 安旭生物股价涨3.12%，报收41.34元，成交金额8487万元，换手率1.62%，振幅6.34%，量比1.99。安旭生物今日主力资金净流入45万元，上一交易日主力净流入20万元。|03月05日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|元道通信|9.05%|#|卓翼科技|7.54%|#|祥明智能|5.65%|#|山东矿机|5.17%|#|本川智能|4.90%|#|新力金融|4.81%|#|三维通信|4.55%|#|翔腾新材|4.12%|#|宜安科技|4.11%|#|武汉凡谷|3.91%|安旭生物所在的医疗器械行业，今日主力净流出3.86亿元，行业排名25/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305161718abe9305e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305161718abe9305e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2517953543","title":"安旭生物涨5.26%创近3月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2517953543","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517953543?lang=zh_cn&edition=full","pubTime":"2025-03-05 11:01","pubTimestamp":1741143682,"startTime":"0","endTime":"0","summary":"03月05日，安旭生物股价大幅上涨，截至11点01分，安旭生物上涨5.26%，报42.20元/股，创近3个月新高，成交4661万元，换手率0.90%，振幅5.86%。资金动向截止发稿，安旭生物获得主力净流入285万元，其中超大单流入13万元，大单流入272万元。主营业务及业绩安旭生物公司主营业务为POCT试剂及仪器的研发、生产与销售。最新财报显示，今年三季报，安旭生物实现营业收入4.03亿元，同比增长27.56%，净利润为1.36亿元，同比减少27.33%，基本每股收益为1.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305110127989c7aa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305110127989c7aa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2516564440","title":"安旭生物03月04日主力净流入20万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516564440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516564440?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:20","pubTimestamp":1741072832,"startTime":"0","endTime":"0","summary":"03月04日, 安旭生物股价涨0.63%，报收40.09元，成交金额3295万元，换手率0.65%，振幅2.69%，量比0.87。安旭生物今日主力资金净流入20万元，上一交易日主力净流出79万元。该股近5个交易日上涨7.60%，主力资金累计净流出583万元；近20日主力资金累计净流出701万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304161202a25e8217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304161202a25e8217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688075"],"gpt_icon":0},{"id":"2516942276","title":"中国脑机接口行业发展与展望：医疗器械专题之脑机接口","url":"https://stock-news.laohu8.com/highlight/detail?id=2516942276","media":"华安证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516942276?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:00","pubTimestamp":1741017600,"startTime":"0","endTime":"0","summary":"政策引导+技术突破，全球脑机接口产业进入高速发展阶段，中国非侵入式脑机接口技术全球领先。中国围绕非侵入式脑机接口方向，实现弯道超车，首创实现“双环路”脑机交互系统，打破了传统脑机接口的信息交互，并极大突破了操控时间的限制，该技术突破使得中国在非侵入式脑机接口领域处于全球领先地位。医疗健康是当前脑机接口最成熟的赛道，覆盖神经疾病诊断、康复治疗及功能替代。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688016","603987","688212","688389","688426","688068","688767","688013","688085","688351","688151","BK0114","688606","600529","688338","600587","688580","688581","688317","688217","600645","603309","688050","688193","688253","688271","688277","688358","688575","603205","688607","603301","600055","688161","BK0251","688273","688468","688114","603222","688298","688656","688399","600807","688289","688075","688139","688576","605369","688366","688677","688301","BK0146","688236","159883","688029","688026","688198","688626","603880","603976","688410","603387","603658","688314","BK0070","688393","688617","688108","688067","688613"],"gpt_icon":0},{"id":"2514108613","title":"安旭生物02月28日遭主力抛售6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514108613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514108613?lang=zh_cn&edition=full","pubTime":"2025-02-28 15:22","pubTimestamp":1740727330,"startTime":"0","endTime":"0","summary":"02月28日, 安旭生物股价跌1.51%，报收38.60元，成交金额3090万元，换手率0.62%，振幅4.03%，量比1.04。安旭生物今日主力资金净流出6万元，连续5日净流出，上一交易日主力净流出48万元。该股近5个交易日上涨0.60%，主力资金累计净流出695万元；近20日主力资金累计净流出666万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228164638abe08573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228164638abe08573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"gpt_icon":0},{"id":"2514357908","title":"公司深度报告：“产品+营销”双轮驱动，塑造家用医疗器械领先品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2514357908","media":"信达证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514357908?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:06","pubTimestamp":1740701178,"startTime":"0","endTime":"0","summary":"鱼跃医疗本期内容提要:核心观点：我们认为在人口老龄化的背景下，居民健康管理及家庭康养需求提升，家用医疗器械产品市场规模有望逐步扩大。公司作为国内领先的家用医疗器械厂商，随着产品管线逐步丰富，品牌影响力不断增强，市场份额有望不断提升，业务有望保持稳健增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808062298957ecb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","600055","688217","688613","688050","603309","688626","603976","603205","600807","BK0251","603387","688576","688253","688067","688358","688277","688389","688767","603658","688399","688410","BK0146","BK0114","688068","688581","688677","688198","688114","600587","688236","688273","688607","688029","688393","688271","688468","600645","688108","688575","603301","688426","688606","688289","688617","688314","688013","688366","603222","688193","603987","600529","688298","BK0070","688151","688075","688212","688301","688338","688656","159883","688139","688161","688085","603880","688580","688351","605369"],"gpt_icon":0},{"id":"2514879501","title":"安旭生物(688075.SH)：2024年度净利润2.01亿元 同比增长42.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514879501","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514879501?lang=zh_cn&edition=full","pubTime":"2025-02-27 17:59","pubTimestamp":1740650354,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安旭生物(688075.SH)发布2024年度业绩快报，报告期内公司实现营业收入5.55亿元，同比增长10.29%;归属于母公司所有者的净利润2.01亿元，同比增长42.06%;归属于母公司所有者的扣除非经常性损益的净利润3539.52万元，同比减少32.38%;基本每股收益1.58元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688075"],"gpt_icon":0},{"id":"2512177851","title":"安旭生物：请参考公司公开信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2512177851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512177851?lang=zh_cn&edition=full","pubTime":"2025-02-19 18:30","pubTimestamp":1739961036,"startTime":"0","endTime":"0","summary":"证券之星消息，安旭生物(688075)02月19日在投资者关系平台上答复投资者关心的问题。投资者：董秘您好！贵司或者子公司是否有打算接入DEEPSEEK或使用AI技术提高精准医疗和基因编辑等?是否有使用AI提高病理诊断效率？安旭生物董秘：尊敬的投资者，您好：请参考公司公开信息，感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900033131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747008663435,"stockEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0154},{"period":"3month","weight":-0.062},{"period":"6month","weight":-0.0942},{"period":"1year","weight":-0.0007},{"period":"ytd","weight":-0.0146}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安旭生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"5935人(较上一季度减少4.47%)","perCapita":"21412股","listingDate":"2021-11-18","address":"浙江省杭州市余杭区莫干山路1418-50号4幢3层(上城科技工业基地)","registeredCapital":"12708万元","survey":"　　杭州安旭生物科技股份有限公司专注于POCT试剂及仪器的研发、生产与销售。公司主要产品为POCT试剂及仪器。公司拥有抗原抗体自主研发生产的生物原料技术平台，以及成熟的免疫层析及干式生化诊断技术平台，发展形成了覆盖毒品检测、传染病检测、慢性病检测、妊娠检测、肿瘤检测、心肌检测、生化检测、过敏原检测八大领域的POCT试剂，产品远销美国、德国、英国、加拿大、俄罗斯、墨西哥、泰国、印尼及波兰等150多个国家，已成为国内少数几家在POCT国际市场能够与跨国体外诊断行业巨头竞争的中国体外诊断产品供应商之一。","listedPrice":78.28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安旭生物,688075,安旭生物股票,安旭生物股票老虎,安旭生物股票老虎国际,安旭生物行情,安旭生物股票行情,安旭生物股价,安旭生物股市,安旭生物股票价格,安旭生物股票交易,安旭生物股票购买,安旭生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}